PARIS, March 29 (Xinhua) -- French pharmaceutical company Sanofi announced Friday the launching of a new manufacturing facility with an investment of 75 million U.S. dollars in Vietnam.
Located at the Saigon High Tech Park, in Ho Chi Minh City, the new state-of-the-art plant will expand Sanofi's manufacturing capacity in Vietnam to meet the fast growing demand of the local pharmaceutical market and will serve as an export platform to the Association of Southeast Asian Nations (ASEAN) countries, the company said in a statement.
"This new production and development center is the largest investment ever made by Sanofi in Vietnam and illustrates our commitment to bringing high quality medicines to a broader population in Vietnam," said Christopher A. Viehbacher, Chief Executive Officer of Sanofi, during the official launch of the construction project.
The project is scheduled to be fully operational by the end of 2015 and will join Sanofi's existing network of 40 manufacturing sites in emerging markets.
The initial capacity of the new plan is designed at 90 million units per year, it would possibly extend up to 150 million units, the Safoni said, adding that the facility will produce high-quality pharmaceuticals and consumer healthcare products.